lipoprotein A

リポタンパク質A

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. リポ蛋白aと心血管疾患lipoprotein a and cardiovascular disease [show details]
  … Elevated serum lipoprotein(a), also referred to as Lp(a), is a risk factor for atherosclerotic cardiovascular disease (ASCVD). There is a causal relationship between Lp(a) excess and the development of …
• 2. リポ蛋白の分類、代謝、およびアテローム性動脈硬化症における役割lipoprotein classification metabolism and role in atherosclerosis [show details]
  …inhibition is discussed separately. Lipoprotein(a) or Lp(a) is a specialized form of LDL that is assembled intrahepatically from apolipoprotein (a) and LDL . Apo(a) links to apolipoprotein B-100 on the …
• 3. 血栓溶解異常による血栓性および出血性疾患thrombotic and hemorrhagic disorders due to abnormal fibrinolysis [show details]
  … lipoprotein has a number of other potentially prothrombotic actions: Lp(a) lipoprotein enhances expression of PAI-2 in blood monocytes, which would inhibit fibrinolysis . Lp(a) lipoprotein binds and inactivates …
• 4. 家族性高コレステロール血症以外の遺伝性のLDLコレステロール代謝異常inherited disorders of ldl cholesterol metabolism other than familial hypercholesterolemia [show details]
  …to, patients with abnormal levels of low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol, triglycerides, or lipoprotein(a). An abnormal level of each of these is the result …
• 5. 成人の脂質異常症へのスクリーニングscreening for lipid disorders in adults [show details]

English Journal

• Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism.

• Pramfalk C, Jakobsson T, Verzijl CRC, Minniti ME, Obensa C, Ripamonti F, Olin M, Pedrelli M, Eriksson M, Parini P.
• Biochimica et biophysica acta. Molecular and cell biology of lipids. 2020 Jun;1865(6)158659.
• In contrast to human hepatocytes in vivo, which solely express acyl-coenzyme A:cholesterol acyltransferase (ACAT) 2, both ACAT1 and ACAT2 (encoded by SOAT1 and SOAT2) are expressed in primary human hepatocytes and in human hepatoma cell lines. Here, we aimed to create hepatocyte-like cells expressin
• PMID 32058035

• The brave new world of genetic testing in the management of the dyslipidaemias.

• Nawawi HM, Chua YA, Watts GF.
• Current opinion in cardiology. 2020 May;35(3)226-233.
• With the exception of familial hypercholesterolaemia, the value of genetic testing for managing dyslipidaemias is not established. We review the genetics of major dyslipidaemias in context of clinical practice. Genetic testing for familial hypercholesterolaemia is valuable to enhance diagnostic prec
• PMID 32097179

• Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.

• Anagnostis P, Bitzer J, Cano A, Ceausu I, Chedraui P, Durmusoglu F, Erkkola R, Goulis DG, Hirschberg AL, Kiesel L, Lopes P, Pines A, van Trotsenburg M, Lambrinoudaki I, Rees M.
• Maturitas. 2020 May;135()82-88.
• Dyslipidemias are common and increase the risk of cardiovascular disease. The menopause transition is associated with an atherogenic lipid profile, with an increase in the concentrations of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), apolipoprotein B (
• PMID 32209279

Japanese Journal

• Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura

• Nishikawa Mana,Shimada Noriaki,Kawazoe Tomohiro,Sawaki Ryo,Ikuta Haruka,Kanzaki Motoko,Fukuoka Kosuke,Fukushima Masaki,Asano Kenichiro
• Internal Medicine 59(7), 983-986, 2020
• … Despite treatment with prednisolone, cyclosporin and low-density lipoprotein-apheresis, MCNS and ITP did not improve. …
• NAID 130007825323

• Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases

• Fukuda Ryosuke,Murakami Tatsuya
• Ｂｉｏｌｏｇｉｃａｌ　＆　Ｐｈａｒｍａｃｅｕｔｉｃａｌ　Ｂｕｌｌｅｔｉｎ 43(4), 596-607, 2020
• <p>Lipoproteins are naturally occurring nanoparticles and their main physiological function is the promotion of lipid metabolism. They can be prepared <i>in vitro</i> for use as drug …
• NAID 130007825271

• Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation

• Izumida Toshihide,Nakamura Yosikazu,Hino Yumika,Ishikawa Shizukiyo
• Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ 27(4), 319-330, 2020
• … <p><b>Aims: </b>Small dense low-density lipoprotein cholesterol (sdLDL-C) and remnant-like particle cholesterol (RLP-C) are the novel atherosclerotic risk factors and might be strongly associated with inflammation. …
• NAID 130007824995

Related Links

• Lipoprotein-A Test: Purpose, Procedure, and Risks

Low-density lipoprotein can be associated with an increased risk for heart attack and stroke. Learn more about a test that can help determine your risk. The Lp(a) test is not commonly used when ...

• 血液・呼吸器内科のお役立ち情報：リポ蛋白(a) ／Lp(a)

リポ蛋白(a) [lipoprotein (a)] LP（a）とは Lp(a)はLDLのアポ蛋白B-100にアポ (a)がS-S結合した脂質で、現在動脈硬化の独立した危険因子と考えられています。 アポ (a)は構造上プラスミノゲン（Plg）と極めて高い相同性を有し、Plgの ...

• Lipoprotein(a) Linked to Heart Attacks - WebMD

Lipoprotein(a) Linked to Heart Attacks Genetic Study Shows Heart Attack Increase From Lipoprotein(a), a Type of Cholesterol By Salynn Boyles From the WebMD Archives June 9, 2009 -- Genetic testing ...

---

★リンクテーブル★

リンク元	「リポ蛋白A」「lipoprotein(a)」「リポタンパク質A」
拡張検索	「apolipoprotein A」「apolipoprotein A-II」「apolipoprotein A-I」「apolipoprotein A2」
関連記事	「A」「Ad」「lipoprotein」「lipoproteins」

「リポ蛋白A」

　　[★]

英

lipoprotein A

関

リポ蛋白(a)、リポタンパク質A

「lipoprotein(a)」

　　[★] アポタンパク質(a)、リポ蛋白(a)

関

lipoprotein A

「リポタンパク質A」

　　[★]

英

lipoprotein A

関

リポ蛋白A

「apolipoprotein A」

　　[★]

アポリポタンパク質A、アポリポ蛋白質A、アポリポタンパクA、アポリポ蛋白A

関

apo A、apoA

「apolipoprotein A-II」

　　[★] アポリポタンパク質AII

「apolipoprotein A-I」

　　[★] アポリポタンパク質AI

「apolipoprotein A2」

　　[★] アポリポタンパク質A2

「A」

　　[★]

• アデニン adenine
• アデノシン adenosine
• アラニン alanine

　 　 　

「Ad」

　　[★]

• アデノウイルス

関

adenoviral、adenovirus

「lipoprotein」

　　[★] リポ蛋白 lipoprotein 　

「lipoproteins」

　　[★] リポ蛋白 lipoprotein